title: Non-cytotoxic CD4 tumour-infiltrating lymphocytes induce responses in patients with metastatic renal cell carcinoma previously treated with interleukin-2.
authors.forename: C
authors.initials: C
authors.lastname: Mathiot
authors.forename: N
authors.initials: N
authors.lastname: Thiounn
authors.forename: E
authors.initials: E
authors.lastname: Tartour
authors.forename: T
authors.initials: T
authors.lastname: Flam
authors.forename: C
authors.initials: C
authors.lastname: Peyret
authors.forename: I
authors.initials: I
authors.lastname: Joyeux
authors.forename: M
authors.initials: M
authors.lastname: Zerbib
authors.forename: M
authors.initials: M
authors.lastname: Brandely
authors.forename: B
authors.initials: B
authors.lastname: Debré
authors.forename: W H
authors.initials: WH
authors.lastname: Fridman
mesh_terms: D015496:CD4-Positive T-Lymphocytes / Q000502:physiology*; D002292:Carcinoma, Renal Cell / Q000556:secondary / Q000628:therapy*; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D007680:Kidney Neoplasms; D016246:Lymphocytes, Tumor-Infiltrating / Q000502:physiology*
chemical_list: D007376:Interleukin-2